Sfoglia per AUTORE
MARCHETTI M
Collezione AOU Alessandria

  

Items : 55

Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA Report. in American journal of hematology / Am J Hematol. 2025 Mar;100(3):358-374. doi: 10.1002/ajh.27565. Epub 2024 Dec 23.
2025
AOU Alessandria
AOU Città della Salute di Torino

D?browska-Iwanicka A; Brunetti SC; Drozd-Soko?owska J; van den Ven L; Fianchi L; Limongelli A; Sciumè M; Leotta D; Bavastro M; Musto P; Delia M; Wolf D; Anastasopoulou AN; Mayer J; Víšek B; Varricchio G; Arellano E; Córdoba R; Cerchione C; Prin R; Cvetanoski M; Mitrovi? M; Aiello TF; Glenthøj A; Gräfe SK; Schönlein M; Hersby DS; Adži?-Vuki?evi? T; Coppola N; et alii...

Treatment of acute and chronic graft-versus-host disease with extracorporeal photopheresis: Update of best practice recommendations from Italian Society of Hemapheresis and Cell Manipulation (SIdEM) and the Italian Transplant Group for Bone Marrow Transplantation, Hematopoietic Stem Cells and Cell Therapy (GITMO). in Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis / Transfus Apher Sci. 2024 Oct;63(5):103990. doi: 10.1016/j.transci.2024.103990. Epub 2024 Aug 13.
2024
AOU Alessandria

Colpo A; Marchetti M; Bianco I; Cruciani F; Ipsevich F; Montanari M; Stanghellini MTL;

Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter study. in Blood advances / Blood Adv. 2024 Nov 13:bloodadvances.2024014984. doi: 10.1182/bloodadvances.2024014984.
2024
AOU Alessandria

Fattizzo B; Marchetti A; Bosi A; Gurnari C; Giannotta JA; Pedone GL; Rossi E; Carrai V; Guido A; Brioschi F; Carpenedo M; Crugnola M; Caramazza D; Leuzzi L; Marchetti M; Merati G; Malato S; Vianello F; Patriarca A; Awada H; Bortolotti M; Canzi M; Bolli N; Capecchi M; Chen F; Artoni A; Maciejewski JP; Barcellini W;

Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes. in The Lancet. Haematology / Lancet Haematol. 2024 Nov;11(11):e862-e872. doi: 10.1016/S2352-3026(24)00251-5. Epub 2024 Oct 9.
2024
AOU Alessandria

Komrokji RS; Lanino L; Ball S; Bewersdorf JP; Marchetti M; Maggioni G; Travaglino E; Al Ali NH; Fenaux P; Platzbecker U; Santini V; Diez-Campelo M; Singh A; Jain AG; Aguirre LE; Tinsley-Vance SM; Schwabkey ZI; Chan O; Xie Z; Brunner AM; Kuykendall AT; Bennett JM; Buckstein R; Bejar R; Carraway HE; DeZern AE; Griffiths EA; Halene S; Hasserjian RP; et alii...

Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022. in EClinicalMedicine / EClinicalMedicine. 2024 Mar 18;71:102553. doi: 10.1016/j.eclinm.2024.102553. eCollection 2024 May.
2024
AOU Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Pagano L; Cornely OA; Koehler P; Rahimli L; Hanáková M; Rá?il Z; Bonanni M; Nygaard M; García-Bordallo D; Çolak GM; Mayer J; Sacchi MV; Krekeler C; Infante MS; Jindra P; Zompi S; Mitrovi? M; Miškovi? B; Mladenovi? M; Coppola N; Otaševi? V; Prattes J; Gavriilaki E; Tragiannidis A; Groh A; Serrano L; Drgo?a ?; Serris A; Gonzaga Y; et alii...

ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft-versus-host disease in adults. in The European respiratory journal / Eur Respir J. 2024 Mar 28;63(3):2301727. doi: 10.1183/13993003.01727-2023. Print 2024 Mar.
2024
AOU Alessandria

Bos S; Murray J; Marchetti M; Cheng GS; Bergeron A; Wolff D; Sander C; Sharma A; Badawy SM; Peric Z; Piekarska A; Pidala J; Raj K; Penack O; Kulkarni S; Beestrum M; Linke A; Rutter M; Coleman C; Tonia T; Schoemans H; Stolz D; Vos R;

Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey. in Infection / Infection. 2024 Jun;52(3):1125-1141. doi: 10.1007/s15010-023-02169-7. Epub 2024 Feb 22.
2024
AOU Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Rasch S; Rahimli L; Cornely OA; Pagano L; Dibos M; Bavastro M; Prattes J; Egger M; Limongelli A; Cvetanoski M; García-Sanz R; Arellano E; Zambrotta GPM; Aiello TF; Wolf D; Núñez-Martín-Buitrago L; Nunes Rodrigues R; Hersby DS; Hanakova M; Víšek B; Cabirta A; Nordlander A; ?er?an M; Gräfe SK; Mladenovi? M; Miškovi? B; Ilhan O; Ammatuna E; Çolak GM; et alii...

2024
AOU Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Dibos M; Cvetanoski M; Bavastro M; Limongelli A; Egger M; Prattes J; García-Sanz R; Aiello TF; Arellano E; Wolf D; Núñez-Martín-Buitrago L; Zambrotta GPM; Hersby DS; Nunes Rodrigues R; Nordlander A; Víšek B; Cabirta A; Gräfe SK; Ammatuna E; Hanakova M; ?er?an M; Çolak GM; Ilhan O; Bara? A; Mladenovi? M; Miškovi? B; Kohn M; Emarah Z; Stojanoski Z; et alii...

Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry. in Hematological oncology / Hematol Oncol. 2024 Jan;42(1):e3240. doi: 10.1002/hon.3240. Epub 2023 Dec 4.
2024
AOU Alessandria
AOU San Luigi di Orbassano

Rahimli L; Marchesi F; Limongelli A; Bavastro M; Rá?il Z; Hanakova M; Aiello TF; Nunes-Rodrigues R; Emarah Z; Arellano E; Quattrone M; Ilhan O; García-Sanz R; Mayer J; Žák P; Ammatuna E; Cordoba R; Zambrotta GPM; Izuzquiza M; Cabirta A; Nordlander A; Obr A; Çolak GM; Szotkowski T; Wolf D; De-Ramón C; Del Principe MI; Marques-De-Almeida J; Dargenio M; et alii...

The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey. in Leukemia & lymphoma / Leuk Lymphoma. 2024 Feb;65(2):199-208. doi: 10.1080/10428194.2023.2280886. Epub 2024 Jan 24.
2024
AOU Alessandria
AOU San Luigi di Orbassano

Gräfe S; Cordoba R; Hersby DS; Ammatuna E; Rá?il Z; Nordlander A; Miškovi? B; Mladenovi? M; Arellano E; Adži?-Vuki?evi? T; Al-Khabori M; Blennow O; Collins GP; Calbacho M; De Jonge N; Demirkan F; Espigado I; Kulasekararaj A; Labrador J; Ormazabal-Vélez I; Bonnani M; Rinaldi I; Glenthøj A; López-García A; Maertens J; Meers S; Méndez GA; Passamonti F; Van Doesum J; et alii...

Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registry. in Haematologica / Haematologica. 2024 Aug 1;109(8):2693-2700. doi: 10.3324/haematol.2023.284678.
2024
AOU Alessandria
AOU San Luigi di Orbassano

Prin R; Wolf D; Arellano E; Ammatuna E; Nordlander A; Cabirta A; Cordoba R; Garcia-Bordallo D; Tragiannidis A; Rodrigues RN; Vehreschild M; Ra?il Z; Hanakova M; Lievin R; Mitrovic M; Garcia-Sanz R; Cvetanoski M; Varricchio G; Bahr NC; Emarah Z; De Ramon C; Meers S; Di Blasi R; Mendez GA; Pantic N; Stojanoski Z; Erben N; Groh A; Cattaneo C; et alii...

Diagnosis and management of Evans syndrome in adults: first consensus recommendations. in The Lancet. Haematology / Lancet Haematol. 2024 Aug;11(8):e617-e628. doi: 10.1016/S2352-3026(24)00144-3. Epub 2024 Jul 2.
2024
AOU Alessandria

Fattizzo B; Marchetti M; Michel M; Cantoni S; Frederiksen H; Giordano G; Glenthøj A; González-López TJ; Murakhovskaya I; Napolitano M; Mingot ME; Arguello M; Patriarca A; Raso S; Vianelli N; Barcellini W;

Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2023 Oct;62(4):106952. doi: 10.1016/j.ijantimicag.2023.106952. Epub 2023 Au
2023
AOU Alessandria
AOU San Luigi di Orbassano

Mladenovi? M; Bavastro M; Limongelli A; Rahimli L; Miškovi? B; Marchetti M; Nordlander A; Blennow O; Cordoba R; Wolf D; Çolak GM; Arellano E; Hersby DS; Gräfe S; Kohn M; Calbacho M; Besson C; Dargenio M; Del Principe MI; Glenthøj A; Fouquet G; Hernández-Rivas JÁ; Labrador J; Merelli M; Pantic N; Mitrovic M; Schönlein M; Gavriilaki E; Tragiannidis A; et alii...

SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemia. in British journal of haematology / Br J Haematol. 2023 May;201(3):411-416. doi: 10.1111/bjh.18606. Epub 2022 Dec 20.
2023
AOU Alessandria
AOU Città della Salute di Torino

Corradini P; Passamonti F; Bertù L; Pulsoni A; Rivela P; Massaia M; Busca A; Falini B; Della Porta MG; Vallisa D; Cattaneo C; Capponi M; Bruna R; Tisi MC; Selleri C; Gozzetti A; Broccoli A; De Carolis L; Morotti A; Romano A; D'Elia GM; Candoni A; Marchetti M; Mancini A; Tiacci E;

Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey. in Blood advances / Blood Adv. 2023 Jun 13;7(11):2645-2655. doi: 10.1182/bloodadvances.2022009578.
2023
AOU Alessandria

van Doesum JA; Salmanton-García J; Marchesi F; Di Blasi R; Falces-Romero I; Cabirta A; Farina F; Besson C; Weinbergerová B; Van Praet J; Schönlein M; López-García A; Lamure S; Guidetti A; De Ramón-Sánchez C; Batini? J; Gavriilaki E; Tragiannidis A; Tisi MC; Plantefeve G; Petzer V; Ormazabal-Vélez I; Marques de Almeida J; Marchetti M; Maertens J; Machado M; Kulasekararaj A; Hernández-Rivas JÁ; Gomes da Silva M; et alii...

Cost-Effectiveness of brexucabtagene autoleucel for relapsed/refractory mantle cell lymphoma. in Leukemia & lymphoma / Leuk Lymphoma. 2023 Jul-Aug;64(8):1442-1450. doi: 10.1080/10428194.2023.2215888. Epub 2023 May 25.
2023
AOU Alessandria

Marchetti M; Visco C;

COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA). in Haematologica / Haematologica. 2023 Jan 1;108(1):22-33. doi: 10.3324/haematol.2022.280847.
2023
AOU Alessandria
AOU Città della Salute di Torino

Hoenigl M; Ammatuna E; Busca A; Corradini P; Rahimli L; Gräfe S; Khostelidi S; Martín-González JA; García-Poutón N; Sacchi MV; Rodrigues RN; Booth S; Sciumè M; Zambrotta G; Hanakova M; El-Ashwah S; Cordoba R; Calbacho M; Bahr NC; Cattaneo C; De Ramón-Sánchez C; Fazzi R; Glenthøj A; Sramek J; Kulasekararaj A; Jindra P; Navrátil M; Piedimonte M; Petzer V; et alii...

SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort. in Hematological oncology / Hematol Oncol. 2023 Feb;41(1):128-138. doi: 10.1002/hon.3092. Epub 2022 Oct 25.
2023
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Visco C; Corradini P; Passamonti F; Bertù L; Guidetti A; Gherlinzoni F; Pagano L; Visani G; Federici AB; Tisi MC; Cudillo L; Galimberti S; Cilloni D; Della Porta MG; Coviello E; Mohamed S; Mauro FR; Gentile M; Gambacorti-Passerini C; Bocchia M; Massaia M; Billio A; Fracchiolla NS; Marchesi F; Scattolin A; Trentin L; Cattaneo C; Derenzini E; Cavo M; et alii...

Nephrological Complications in Hemoglobinopathies: SITE Good Practice. in Journal of clinical medicine / J Clin Med. 2023 Dec 2;12(23):7476. doi: 10.3390/jcm12237476.
2023
AOU Alessandria

Ruffo GB; Russo R; Casini T; Lombardini L; Orecchia V; Voi V; Origa R; Forni GL; Marchetti M; Gigante A; Garibotto G; Maggio A; De Franceschi L;

Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings. in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases / Int J Infect Dis. 2023 Dec;137:98-110. doi: 10.1016/j.ijid.2023.10.013. Epub 2023 Oct 18.
2023
AOU Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Pagano L; Cordoba R; Cornely OA; Hanakova M; Rahimli L; Sacchi MV; Nunes Rodrigues R; Hersby DS; Ammatuna E; Cabirta A; Zambrotta GPM; Nordlander A; Arellano E; Mladenovi? M; Aiello TF; Núñez-Martín-Buitrago L; Gräfe SK; Miškovi? B; Emarah Z; García-Sanz R; Çolak GM; Wolf D; Limongelli A; Ilhan O; Calbacho M; Bara? A; Bavastro M; Merelli M; Biernat MM; et alii...

The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL. in American journal of hematology / Am J Hematol. 2023 Dec;98(12):1856-1868. doi: 10.1002/ajh.27093. Epub 2023 Sep 29.
2023
AOU Alessandria
AOU Città della Salute di Torino

Montserrat E; Cuneo A; Rambaldi A; Coscia M; Iyengar S; Varettoni M; Vitale C; Vandenberghe E; Yassin M; Pocali B; Wróbel T; Segundo LYS; Wasik-Szczepanek E; van Gelder M; van Kampen R; Tonino SH; Van Der Spek E; Te Raa D; Shrestha A; Saghumyan G; Reda G; Mirás F; Milosevic I; Gutwein O; Karlsson LK; Del Poeta G; Capasso A; Tadmor T; Sportoletti P; et alii...

2023
AOU Alessandria
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino

Fazi P; Vignetti M; Guarini A; Cuneo A; Piciocchi A; De Propris MS; Nanni M; Del Giudice I; Neri A; De Novi LA; Albano F; Vitale C; Visentin A; Pietrasanta D; Mattiello V; Molinari MC; Liberati AM; Giordano A; Patrizi VB; Gottardi D; Galieni P; Deodato M; Arcari A; Musuraca G; Tani M; Levato L; Marchetti M; Massaia M; Rigolin GM; et alii...

Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts. in American journal of hematology / Am J Hematol. 2023 Aug;98(8):E204-E208. doi: 10.1002/ajh.26960. Epub 2023 May 24.
2023
AOU Alessandria
ASL Città di Torino
ASL Torino 4
AO Ordine Mauriziano
AOU Città della Salute di Torino

Della Porta MG; Santini V; Naldi I; Pasini P; Giordano L; Finelli C; Turrini M; Sancetta R; Selleri C; Tanasi I; Tosi P; Frigeni M; Marchetti M; Norata M; Grimaldi D; Fianchi L; Galimberti S; Ferrara F; Castelli A; Di Bona E; Di Veroli A; Bono R; Calvisi A; Rivoli G; Molteni A; Nicolino B; Occhini U; Leuzzi L; Genua A; et alii...

Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry. in EClinicalMedicine / EClinicalMedicine. 2023 Apr;58:101939. doi: 10.1016/j.eclinm.2023.101939. Epub 2023 Apr 6.
2023
AOU Alessandria
AOU San Luigi di Orbassano

Blennow O; Nordlander A; Cabirta A; Cattaneo C; Merelli M; Hernández-Rivas JÁ; Aujayeb A; Jiménez M; Nucci M; Papa MV; Plantefeve G; Del Principe MI; Duléry R; Anastasopoulou AN; De Jonge N; Tascini C; Fernández N; Batini? J; Ormazabal-Vélez I; Cuccaro A; Lahmer T; Valkovi? T; Biernat MM; Besson C; Finizio O; Marques de Almeida J; Marchetti M; Weinbergerová B; Delia M; et alii...

Diagnosis and Management of Cardiovascular Risk in Patients with Polycythemia Vera. in Vascular health and risk management / Vasc Health Risk Manag. 2023 Nov 22;19:765-778. doi: 10.2147/VHRM.S429995. eCollection 2023.
2023
AOU Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Milan A; Bruno B; Rapezzi D; Biolé CA; Sartori C; Beggiato E; Marchetti M; Melchio R; Benevolo G;

Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry. in Therapeutic advances in hematology / Ther Adv Hematol. 2023 Mar 11;14:20406207231154706. doi: 10.1177/20406207231154706. eCollection 2023
2023
AOU Alessandria
AOU San Luigi di Orbassano

Arellano E; Wolf D; Gräfe SK; Nordlander A; Cabirta A; Collins GP; Demirkan F; Jiménez M; Ledoux MP; Maertens J; Mitra ME; Magliano G; Samarkos M; Schönlein M; Cernan M; Blennow O; ?olovi? N; Duarte R; Bergantim R; Jaksic O; Meers S; Prezioso L; Bonuomo V; Buquicchio C; Espigado I; Petzer V; Glenthøj A; Žák P; Bilgin YM; et alii...

Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry. in Frontiers in immunology / Front Immunol. 2023 Feb 24;14:1125030. doi: 10.3389/fimmu.2023.1125030. eCollection 2023.
2023
AOU Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Cornely OA; Dargenio M; Rahimli L; Gavriilaki E; Groh A; Itri F; López-García A; Petzer V; Tragiannidis A; Van Praet J; Berg Venemyr C; Gräfe S; Cabirta A; Hanakova M; Dragonetti G; Karlsson LK; Zambrotta GPM; Nordlander A; Zompi S; Antoniadou A; Tsirigotis P; Ammatuna E; Ilhan O; Falces-Romero I; Magliano G; Marchetti M; De Kort E; Ribera-Santa Susana JM; Kulasekararaj A; et alii...

2022
AOU Alessandria

Casale M; Baldini M; Del Monte P; Gigante A; Grandone A; Origa R; Poggi M; Gadda F; Lai R; Marchetti M; Forni GL;

Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey. in Cancers / Cancers (Basel). 2022 Nov 10;14(22):5530. doi: 10.3390/cancers14225530.
2022
AOU Alessandria
AOU San Luigi di Orbassano

Berg Venemyr C; Nordlander A; Çolak GM; Sacchi MV; Mladenovi? M; Gräfe S; Sciumè M; Rahimli L; Aujayeb A; Bilgin YM; Cuccaro A; Drgo?a ?; Hoenigl M; Pinczés LI; Maertens J; Meers S; Ormazabal-Vélez I; Samarkos M; Szotkowski T; Verga L; Al-Khabori M; Batini? J; Bergantim R; Del Principe MI; Buquicchio C; Erben N; Garcia-Vidal C; Jiménez M; Magliano G; et alii...

Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients. in British journal of haematology / Br J Haematol. 2022 Nov;199(3):463-467. doi: 10.1111/bjh.18429. Epub 2022 Sep 5.
2022
AOU Alessandria
AO Cuneo

Massaia M; Ladetto M; Pistello M; Lai M; Rapezzi D; Marchetti M; Gaidano V; Ucciero MAM; Mahmoud AM; Patriarca A; Ferrante D; De Andrea M; Martuscelli L; Griffante G; Borgogna C; Bruna R; Gaidano G; Gariglio M; Borgogna C; Bruna R; Griffante G; Martuscelli L; De Andrea M; Ferrante D; Patriarca A; Mahmoud AM; Ucciero MAM; Gaidano V; Marchetti M; et alii...

Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report. in HemaSphere / Hemasphere. 2022 Oct 25;6(11):e789. doi: 10.1097/HS9.0000000000000789. eCollection 2022 Nov.
2022
AOU Alessandria
AOU Città della Salute di Torino

Berg Venemyr C; Cornely OA; Ammatuna E; Gräfe S; Wolf D; Arellano E; Çolak GM; Koehler P; Rahimli L; Busca A; Corradini P; Hoenigl M; Prezioso L; Marchetti M; Meers S; Buquicchio C; Pinczés LI; de Jonge N; Soto-Silva A; Sili U; Serrano L; Aujayeb A; Espigado I; Dargenio M; Farina F; Schönlein M; Chanut M; Petzer V; van Doesum J; et alii...

Comparative Clinical Value of Pharmacologic Therapies for B-Cell Chronic Lymphocytic Leukemia: An Umbrella Analysis. in Journal of clinical medicine / J Clin Med. 2022 Mar 28;11(7):1868. doi: 10.3390/jcm11071868.
2022
ASL Asti
AOU Alessandria

Bertassello C; Rivela P; Marchetti M; Canicattì M;

2022
AOU Alessandria

Casale M; Baldini MI; Del Monte P; Gigante A; Grandone A; Origa R; Poggi M; Gadda F; Lai R; Marchetti M; Forni GL;

COVID-19 and hairy-cell leukemia: an EPICOVIDEHA survey. in Blood advances / Blood Adv. 2022 Jul 12;6(13):3870-3874. doi: 10.1182/bloodadvances.2022007357.
2022
AOU Alessandria
AOU Città della Salute di Torino

Passamonti F; Pagliuca A; Koehler P; Klimko N; Corradini P; Hoenigl M; Busca A; Zompi S; Sacchi MV; Nunes Rodrigues R; Nordlander A; Essame J; Cordoba R; Batini? J; Bergantim R; Bilgin YM; Blennow O; Cattaneo C; Duarte RF; Emarah Z; Gomes da Silva M; González-López TJ; Kulasekararaj A; Ledoux MP; López-García A; Merelli M; Prezioso L; Ilhan O; Seval GC; et alii...

2022
AOU Alessandria
AO Cuneo

Gariglio M; Massaia M; Gaidano G; Ladetto M; Lai M; Pistello M; Rapezzi D; Marchetti M; Gaidano V; Mahmoud AM; Patriarca A; Ferrante D; Griffante G; Martuscelli L; De Andrea M; Borgogna C; Bruna R;

A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study. in Blood advances / Blood Adv. 2022 Jan 11;6(1):327-338. doi: 10.1182/bloodadvances.2021005691.
2022
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Merli F; Krampera M; Corradini P; Passamonti F; Lanza F; Candoni A; Conconi A; Tosi P; Vallisa D; Venditti A; Selleri C; La Barbera EO; Gambacorti-Passerini C; Visani G; Rigacci L; Armiento D; Cilloni D; Corso A; Gherlinzoni F; Tafuri A; Galimberti S; Bocchia M; Cardinali V; Turrini M; Trentin L; Della Porta M; Scattolin A; Tisi MC; Cuneo A; et alii...

Pharmacoeconomic considerations for acute myeloid leukemia pharmacotherapy. in Expert opinion on pharmacotherapy / Expert Opin Pharmacother. 2022 Feb;23(2):263-272. doi: 10.1080/14656566.2021.2014453. Epub 2021 Dec
2022
AOU Alessandria

Marchetti M; Albertin L; Limberti G; Canicattì M;

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey. in Blood / Blood. 2022 Dec 29;140(26):2773-2787. doi: 10.1182/blood.2022017257.
2022
AOU Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Corradini P; Pagliuca A; Passamonti F; Bonanni M; Labrador J; Rahimli L; Verga L; Cattaneo C; Adži?-Vuki?evi? T; Machado M; Gräfe S; Sili U; Hanáková M; Nucci M; Mladenovi? M; Liévin R; Prezioso L; Rá?il Z; Guidetti A; Demirkan F; Sacchi MV; Fernández N; Zambrotta G; Fouquet G; Marchetti M; Batini? J; Aujayeb A; de Jonge N; de Ramón C; et alii...

Lack of efficacy of convalescent plasma in COVID-19 patients with concomitant hematological malignancies: An Italian retrospective study. in Hematological oncology / Hematol Oncol. 2022 Dec;40(5):857-863. doi: 10.1002/hon.3060. Epub 2022 Aug 14.
2022
AOU Alessandria

Lanza F; Monaco F; Ciceri F; Cairoli R; Sacchi MV; Guidetti A; Marchetti M; Massaia M; Arcaini L; Krampera M; Mohamed S; Gherlinzoni F; Mecucci C; Gentile M; Romano I; Venditti A; Ruggeri M; Ferrero D; Coviello E; Fabbri E; Corradini P; Passamonti F;

Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL. in Journal of hematology & oncology / J Hematol Oncol. 2022 Aug 26;15(1):116. doi: 10.1186/s13045-022-01333-0.
2022
AOU Alessandria

Antic D; Milic N; Chatzikonstantinou T; Scarfò L; Otasevic V; Rajovic N; Allsup D; Alonso Cabrero A; Andres M; Baile Gonzales M; Capasso A; Collado R; Cordoba R; Cuéllar-García C; Correa JG; De Paoli L; De Paolis MR; Del Poeta G; Dimou M; Doubek M; Efstathopoulou M; El-Ashwah S; Enrico A; Espinet B; Farina L; Ferrari A; Foglietta M; Lopez-Garcia A; García-Marco JA; et alii...

Old and New Drugs for Chronic Lymphocytic Leukemia: Lights and Shadows of Real-World Evidence. in Journal of clinical medicine / J Clin Med. 2022 Apr 7;11(8):2076. doi: 10.3390/jcm11082076.
2022
AOU Alessandria
AOU Città della Salute di Torino

Coscia M; Scarfò L; Visentin A; Vasile A; Rigolin GM; Vitale C; Marchetti M; Cuneo A;

Appropriate management of polycythaemia vera with cytoreductive drug therapy: European LeukemiaNet 2021 recommendations. in The Lancet. Haematology / Lancet Haematol. 2022 Apr;9(4):e301-e311. doi: 10.1016/S2352-3026(22)00046-1.
2022
AOU Alessandria

Marchetti M; Vannucchi AM; Griesshammer M; Harrison C; Koschmieder S; Gisslinger H; Álvarez-Larrán A; De Stefano V; Guglielmelli P; Palandri F; Passamonti F; Barosi G; Silver RT; Hehlmann R; Kiladjian JJ; Barbui T;

B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA). in Frontiers in oncology / Front Oncol. 2022 Oct 3;12:992137. doi: 10.3389/fonc.2022.992137. eCollection 2022.
2022
AOU Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Busca A; Guidetti A; Glenthøj A; Collins GP; Bonuomo V; Sili U; Seval GC; Hernández-Rivas JÁ; Pagano L; Calbacho M; Giordano A; Cornely OA; Cuccaro A; Marchetti M; Navrátil M; Prezioso L; Nunes-Rodrigues R; Adži?-Vuki?evi? T; De Jonge N; Mladenovi? M; Hanakova M; Zambrotta GPM; Schönlein M; Hoenigl M; Rá?il Z; Nordlander A; Batini? J; Samarkos M; Bilgin YM; et alii...

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA). in Journal of hematology & oncology / J Hematol Oncol. 2021 Oct 14;14(1):168. doi: 10.1186/s13045-021-01177-0.
2021
AOU Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Nordlander A; Borbényi Z; Çolak GM; Hanakova M; El-Ashwah S; Shapetska M; Karlsson LK; Regalado-Artamendi I; Gonzaga Y; Nygaard M; Batini? J; Essame J; Mancini V; Shwaylia H; Sciumè M; Núñez-Martín-Buitrago L; Nunes-Rodrigues R; Ammatuna E; Obr A; Herbrecht R; Izuzquiza M; Oberti M; Salvini M; Ciceri F; Booth S; López-García A; Sacchi MV; Mayer J; Bonuomo V; et alii...

Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report. in Hematological oncology / Hematol Oncol. 2021 Oct;39(4):570-574. doi: 10.1002/hon.2899. Epub 2021 Jul 13.
2021
AOU Alessandria
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino

Pietrasanta D; Foà R; Chiarenza A; Penna G; Orsucci L; Levato L; Gentile M; Sanna A; Gozzetti A; Gattei V; Gottardi D; Derenzini E; Murru R; Leone M; Baratè C; Olivieri J; Tisi MC; Stefoni V; Malerba L; Ibatici A; Del Poeta G; Varettoni M; Chiurazzi F; Marasca R; Farina L; Re F; De Paoli L; Foglietta M; Giordano A; et alii...

Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs. in Blood / Blood. 2021 Jun 24;137(25):3507-3517. doi: 10.1182/blood.2020008201.
2021
AOU Alessandria
AOU Città della Salute di Torino

Gaidano G; Tedeschi A; Scarfò L; Cuneo A; Trentin L; Reda G; Orsucci L; De Paoli L; Montalbano MC; Perutelli F; Boccellato E; Gentile M; Pennese E; Rivela P; Marchetti M; Murru R; Laurenti L; Rigolin GM; Cassin R; Vassallo F; Visentin A; Zamprogna G; Schiattone L; Porrazzo M; Griggio V; Salvetti C; Vitale C; Mauro FR; Foà R; et alii...

2021
AOU Alessandria
AO Ordine Mauriziano
AOU Città della Salute di Torino

Cuneo A; Foà R; Piciocchi A; Rigolin GM; Guarini A; Neri A; Fazi P; Raponi S; Nanni M; Della Starza I; De Propris MS; Del Giudice I; Ruocco V; Varettoni M; Ibatici A; Murru R; Laurenti L; Gentile M; Chiarenza A; Gozzetti A; Molinari A; Zinzani PL; Gottardi D; Musuraca G; Tani M; Orsucci L; Re F; Liberati AM; Ilariucci F; et alii...

Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study. in Blood / Blood. 2021 Dec 23;138(25):2727-2730. doi: 10.1182/blood.2021011883.
2021
AOU Alessandria

Rigolin GM; Del Giudice I; Bardi A; Melandri A; García-Jacobo RE; Cura F; Raponi S; Ilari C; Cafforio L; Piciocchi A; Arena V; Reda G; Albano F; Molica S; Sportoletti P; Trentin L; Marchetti M; Nanni M; Peragine N; Mariglia P; Vignetti M; Guarini A; Mauro FR; Foà R; Cuneo A;

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study. in Leukemia / Leukemia. 2021 Dec;35(12):3444-3454. doi: 10.1038/s41375-021-01450-8. Epub 2021 Nov 1.
2021
AOU Alessandria
AOU Città della Salute di Torino

Tadmor T; Stavroyianni N; Stanca O; Sportoletti P; Špa?ek M; Šimkovi? M; Shrestha A; Saghumyan G; Ruchlemer R; Rigolin GM; Reda G; Qvist K; Quaresmini G; Quaglia FM; Piskunova I; Popov VM; Pavlovsky MA; Papaioannou M; Orsucci L; Olivieri J; Rodrigues RN; Niemann CU; Munir T; Murru R; Morawska M; Motta M; Mirás F; Milosevic I; Mauro FR; et alii...

Cost-Effectiveness of Post-Autotransplant Lenalidomide in Persons with Multiple Myeloma. in Mediterranean journal of hematology and infectious diseases / Mediterr J Hematol Infect Dis. 2021 May 1;13(1):e2021034. doi: 10.4084/MJHID.2021.034. eCollection 2
2021
AOU Alessandria

Marchetti M; Gale RP; Barosi G;

2020
AOU Alessandria
AOU Città della Salute di Torino

Rossi D; Ortiz Pareja M; Papaioannou M; Hakobyan Y; Kalashnikova O; Enrico A; Doubek M; Dimou M; Andres M; Nikitin E; Dos Santos G; Chiarenza A; Barna G; Pocali B; Yassin M; Sportoletti P; Popov VM; Orsucci L; Malerba L; Kersting S; Kater AP; Jaksic O; Herold T; Herishanu Y; Foglietta M; Gentile M; Farina L; De Paolis MR; Del Poeta G; et alii...

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. in The Lancet. Haematology / Lancet Haematol. 2020 Oct;7(10):e737-e745. doi: 10.1016/S2352-3026(20)30251-9. Epub 2020 Aug 13.
2020
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Corradini P; Pagano L; Bertù L; Corrao G; Grossi PA; Franchi M; Oberti M; Zappasodi P; Visco C; Armiento D; Pane F; Galieni P; Rigacci L; Pinto A; Fava C; Candoni A; Venditti A; Federici AB; Musto P; Marchesi F; Gentile M; Bocchia M; Olivieri A; Di Renzo N; Ferrandina C; Ortu La Barbera E; Selleri C; Scattolin AM; Luppi M; et alii...

2020
ASL Asti
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Larocca A; Romano A; Sonneveld P; Ria R; Musto P; Liberati AM; Offidani M; Giuliani N; Marchetti M; Mosca-Siez ML; de Fabritiis P; Gobbi M; Ballanti S; Cellini C; Grasso M; Monaco F; Ronconi S; Pescosta N; Di Lullo G; Capra A; Belotti A; Petrucci MT; Boccadoro M; Zambello R; Mina R;

2020
AOU Alessandria

Penack O; Marchetti M; Ruutu T; Aljurf M; Bacigalupo A; Bonifazi F; Ciceri F; Cornelissen J; Malladi R; Duarte RF; Giebel S; Greinix H; Holler E; Lawitschka A; Mielke S; Mohty M; Arat M; Nagler A; Passweg J; Schoemans H; Socié G; Solano C; Vrhovac R; Zeiser R; Kröger N; Basak GW;

COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure. in Annals of hematology / Ann Hematol. 2020 Aug;99(8):1701-1707. doi: 10.1007/s00277-020-04138-8. Epub 2020 Jun 24.
2020
AOU Alessandria

Marchetti M;